Literature DB >> 36228916

East Africa International Center of Excellence for Malaria Research: Summary of Key Research Findings.

Joaniter I Nankabirwa1,2, John Rek1, Emmanuel Arinaitwe1, Jane Frances Namuganga1, Sam L Nsobya1, Victor Asua1, Henry D Mawejje1, Adrienne Epstein3, Bryan Greenhouse4, Isabel Rodriguez-Barraquer4, Jessica Briggs4, Paul J Krezanoski4, Philip J Rosenthal4, Melissa Conrad4, David Smith5, Sarah G Staedke6, Chris Drakeley6, Teun Bousema7, Chiara Andolina7, Martin J Donnelly8, Moses R Kamya1,2, Grant Dorsey4.   

Abstract

The Program for Resistance, Immunology, Surveillance, and Modeling of Malaria (PRISM) has been conducting malaria research in Uganda since 2010 to improve the understanding of the disease and measure the impact of population-level control interventions in the country. Here, we will summarize key research findings from a series of studies addressing routine health facility-based surveillance, comprehensive cohort studies, studies of the molecular epidemiology, and transmission of malaria, evaluation of antimalarial drug efficacy, and resistance across the country, and assessments of insecticide resistance. Among our key findings are the following. First, we found that in historically high transmission areas of Uganda, a combination of universal distribution of long-lasting insecticidal-treated nets (LLINs) and sustained indoor residual spraying (IRS) of insecticides lowered the malaria burden greatly, but marked resurgences occurred if IRS was discontinued. Second, submicroscopic infections are common and key drivers of malaria transmission, especially in school-age children (5-15 years). Third, markers of drug resistance have changed over time, with new concerning emergence of markers predicting resistance to artemisinin antimalarials. Fourth, insecticide resistance monitoring has demonstrated high levels of resistance to pyrethroids, appreciable impact of the synergist piperonyl butoxide to pyrethroid susceptibility, emerging resistance to carbamates, and complete susceptibility of malaria vectors to organophosphates, which could have important implications for vector control interventions. Overall, PRISM has yielded a wealth of information informing researchers and policy-makers on the malaria burden and opportunities for improved malaria control and eventual elimination in Uganda. Continued studies concerning all the types of surveillance discussed above are ongoing.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36228916      PMCID: PMC9294681          DOI: 10.4269/ajtmh.21-1285

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  8 in total

1.  Promoting cancer genomics research in Africa: a roadmap.

Authors:  Folakemi T Odedina; Solomon Rotimi
Journal:  Nat Rev Cancer       Date:  2021-07       Impact factor: 60.716

2.  C679X loss-of-function PCSK9 variant lowers fasting glucose levels in a black South African population: A longitudinal study.

Authors:  Tinashe Chikowore; Marike Cockeran; Karin R Conradie; Tertia van Zyl
Journal:  Diabetes Res Clin Pract       Date:  2018-09-15       Impact factor: 5.602

3.  Computational biology and bioinformatics in Nigeria.

Authors:  Segun A Fatumo; Moses P Adoga; Opeolu O Ojo; Olugbenga Oluwagbemi; Tolulope Adeoye; Itunuoluwa Ewejobi; Marion Adebiyi; Ezekiel Adebiyi; Clement Bewaji; Oyekanmi Nashiru
Journal:  PLoS Comput Biol       Date:  2014-04-24       Impact factor: 4.475

Review 4.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

5.  H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in Africa.

Authors:  Nicola J Mulder; Ezekiel Adebiyi; Raouf Alami; Alia Benkahla; James Brandful; Seydou Doumbia; Dean Everett; Faisal M Fadlelmola; Fatima Gaboun; Simani Gaseitsiwe; Hassan Ghazal; Scott Hazelhurst; Winston Hide; Azeddine Ibrahimi; Yasmina Jaufeerally Fakim; C Victor Jongeneel; Fourie Joubert; Samar Kassim; Jonathan Kayondo; Judit Kumuthini; Sylvester Lyantagaye; Julie Makani; Ahmed Mansour Alzohairy; Daniel Masiga; Ahmed Moussa; Oyekanmi Nash; Odile Ouwe Missi Oukem-Boyer; Ellis Owusu-Dabo; Sumir Panji; Hugh Patterton; Fouzia Radouani; Khalid Sadki; Fouad Seghrouchni; Özlem Tastan Bishop; Nicki Tiffin; Nzovu Ulenga
Journal:  Genome Res       Date:  2015-12-01       Impact factor: 9.438

6.  The Nigerian Bioinformatics and Genomics Network (NBGN): a collaborative platform to advance bioinformatics and genomics in Nigeria.

Authors:  Segun Fatumo; ThankGod E Ebenezer; Chinwe Ekenna; Itunuoluwa Isewon; Umar Ahmad; Charles Adetunji; Elijah Kolawole Oladipo; Marion Adebiyi; Ezekiel Adebiyi; Oyekanmi Nashiru
Journal:  Glob Health Epidemiol Genom       Date:  2020-07-15

Review 7.  Evaluating the promise of inclusion of African ancestry populations in genomics.

Authors:  Amy R Bentley; Shawneequa L Callier; Charles N Rotimi
Journal:  NPJ Genom Med       Date:  2020-02-25       Impact factor: 8.617

Review 8.  Vitamin D: Possible Therapeutic Roles in Hepatocellular Carcinoma.

Authors:  Isaacson B Adelani; Oluwakemi A Rotimi; Emmanuel N Maduagwu; Solomon O Rotimi
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.